BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991;325:1008-16. [PMID: 1886623 DOI: 10.1056/NEJM199110033251406] [Cited by in Crossref: 213] [Cited by in F6Publishing: 84] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Tahara T, Shibata T, Okubo M, Ishizuka T, Kawamura T, Yamashita H, Nakamura M, Nakagawa Y, Nagasaka M, Arisawa T. Effect of RANTES gene promoter genotypes in patients with ulcerative colitis. Biomed Rep. 2014;2:602-606. [PMID: 24944817 DOI: 10.3892/br.2014.287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Liu Z, Feng BS, Yang SB, Chen X, Su J, Yang PC. Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease. J Biol Chem. 2012;287:3591-3597. [PMID: 22158873 DOI: 10.1074/jbc.m111.304949] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
3 Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY. Crohn’s disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11(31): 4833-4837 [PMID: 16097053 DOI: 10.3748/wjg.v11.i31.4833] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
4 Yamada T, Hino S, Iijima H, Genda T, Aoki R, Nagata R, Han KH, Hirota M, Kinashi Y, Oguchi H, Suda W, Furusawa Y, Fujimura Y, Kunisawa J, Hattori M, Fukushima M, Morita T, Hase K. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis. EBioMedicine 2019;48:513-25. [PMID: 31521614 DOI: 10.1016/j.ebiom.2019.09.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
5 Rigoli L, Romano C, Caruso RA, Presti MAL, Bella CD, Procopio V, Giudice GL, Amorini M, Costantino G, Sergi MD, Cuppari C, Calabrò GE, Gallizzi R, Salpietro CD, Fries W. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol 2008; 14(28): 4454-4461 [PMID: 18680223 DOI: 10.3748/wjg.14.4454] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
6 Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2008;151:165-173. [PMID: 18005263 DOI: 10.1111/j.1365-2249.2007.03539.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
7 Ishii H, Isomoto H, Shikuwa S, Hayashi T, Inoue N, Yamaguchi N, Ohnita K, Nanashima A, Ito M, Nakao K, Kohno S. Peyer's Patches in the Terminal Ileum in Ulcerative Colitis: Magnifying Endoscopic Findings. J Clin Biochem Nutr 2010;46:111-8. [PMID: 20216943 DOI: 10.3164/jcbn.09-77] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Shugart YY, Silverberg MS, Duerr RH, Taylor KD, Wang MH, Zarfas K, Schumm LP, Bromfield G, Steinhart AH, Griffiths AM, Kane SV, Barmada MM, Rotter JI, Mei L, Bernstein CN, Bayless TM, Langelier D, Cohen A, Bitton A, Rioux JD, Cho JH, Brant SR. An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. Genes Immun 2008;9:161-7. [PMID: 18246054 DOI: 10.1038/sj.gene.6364460] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
9 Banskota S, Wang H, Kwon YH, Gautam J, Gurung P, Haq S, Hassan FMN, Bowdish DM, Kim JA, Carling D, Fullerton MD, Steinberg GR, Khan WI. Salicylates Ameliorate Intestinal Inflammation by Activating Macrophage AMPK. Inflamm Bowel Dis 2021;27:914-26. [PMID: 33252129 DOI: 10.1093/ibd/izaa305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, Kohno S. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005; 11(27): 4188-4193 [PMID: 16015687 DOI: 10.3748/wjg.v11.i27.4188] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kim W, Yang Y, Kim D, Jeong S, Yoo JW, Yoon JH, Jung Y. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes. Drug Des Devel Ther 2017;11:419-29. [PMID: 28243064 DOI: 10.2147/DDDT.S129922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
12 Magyari L, Faragó B, Bene J, Horvatovich K, Lakner L, Varga M, Figler M, Gasztonyi B, Mózsik G, Melegh B. No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn’s disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol 2007; 13(15): 2205-2208 [PMID: 17465502 DOI: 10.3748/wjg.v13.i15.2205] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
13 Shaked A, Colonna JO, Goldstein L, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg. 1992;215:598-603; discussion 604-605. [PMID: 1632681 DOI: 10.1097/00000658-199206000-00006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 2.1] [Reference Citation Analysis]
14 Levine TS, Tzardi M, Mitchell S, Sowter C, Price AB. Diagnostic difficulty arising from rectal recovery in ulcerative colitis. J Clin Pathol 1996;49:319-23. [PMID: 8655709 DOI: 10.1136/jcp.49.4.319] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
15 Yen CC, Chen YC, Wu MT, Wang CC, Wu YT. Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. Int J Nanomedicine 2018;13:669-80. [PMID: 29440893 DOI: 10.2147/IJN.S154824] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 11.8] [Reference Citation Analysis]
16 Tahara T, Shibata T, Okubo M, Ishizuka T, Kawamura T, Yamashita H, Nakamura M, Nakagawa Y, Nagasaka M, Arisawa T, Ohmiya N, Hirata I. Heat-shock protein 70-2 BB genotype is associated with reduced risks of the steroid-dependent and refractory phenotypes of ulcerative colitis. Biomed Rep 2014;2:555-8. [PMID: 24944807 DOI: 10.3892/br.2014.288] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
17 Trapecar M, Communal C, Velazquez J, Maass CA, Huang YJ, Schneider K, Wright CW, Butty V, Eng G, Yilmaz O, Trumper D, Griffith LG. Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids. Cell Syst 2020;10:223-239.e9. [PMID: 32191873 DOI: 10.1016/j.cels.2020.02.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
18 Kim DH, Cheon JH, Park JJ, Yoon JY, Moon CM, Hong SP, Kim TI, Kim WH. Clinical outcomes and predictive factors for response after the first course of corticosteroid therapy in patients with Crohn’s disease. Gut Liver. 2013;7:58-65. [PMID: 23423699 DOI: 10.5009/gnl.2013.7.1.58] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
19 Hiyama S, Iijima H, Kawai S, Mukai A, Shiraishi E, Iwatani S, Yamaguchi T, Araki M, Hayashi Y, Shinzaki S, Mizushima T, Tsujii M, Takehara T. Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitis. Intest Res 2016;14:314-21. [PMID: 27799882 DOI: 10.5217/ir.2016.14.4.314] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009;29:303-310. [PMID: 19160029 DOI: 10.1007/s10875-008-9272-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
21 Chiu CC, Ching YH, Wang YC, Liu JY, Li YP, Huang YT, Chuang HL. Monocolonization of germ-free mice with Bacteroides fragilis protects against dextran sulfate sodium-induced acute colitis. Biomed Res Int 2014;2014:675786. [PMID: 24971344 DOI: 10.1155/2014/675786] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
22 Okazaki K, Nakase H, Watanabe N, Tabata Y, Ikada Y, Chiba T. Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis. J Gastroenterol. 2002;37 Suppl 14:44-52. [PMID: 12572865 DOI: 10.1007/bf03326413] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Peng YJ, Shen TL, Chen YS, Mersmann HJ, Liu BH, Ding ST. Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease. J Biomed Sci 2018;25:24. [PMID: 29540173 DOI: 10.1186/s12929-018-0419-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
24 Tan SY, Wu PB, Zhang G, Luo HS, Yao WM. Association between macrophage migration inhibitory factor _173G/C polymorphism and inflammatory bowel disease: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2013; 21(12): 1140-1145 [DOI: 10.11569/wcjd.v21.i12.1140] [Reference Citation Analysis]
25 Lee JO, Kim JH, Kim S, Kim MY, Hong YH, Kim HG, Cho JY. Gastroprotective effects of the nonsaponin fraction of Korean Red Ginseng through cyclooxygenase-1 upregulation. J Ginseng Res 2020;44:655-63. [PMID: 32617046 DOI: 10.1016/j.jgr.2019.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
26 Cheema AK, Suman S, Kaur P, Singh R, Fornace AJ Jr, Datta K. Long-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposure. PLoS One 2014;9:e87079. [PMID: 24475228 DOI: 10.1371/journal.pone.0087079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
27 Han Y, Zhao Q, Tang C, Li Y, Zhang K, Li F, Zhang J. Butyrate Mitigates Weanling Piglets From Lipopolysaccharide-Induced Colitis by Regulating Microbiota and Energy Metabolism of the Gut-Liver Axis. Front Microbiol 2020;11:588666. [PMID: 33363521 DOI: 10.3389/fmicb.2020.588666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wills A, Hovell CJ. Neurological complications of enteric disease. Gut. 1996;39:501-504. [PMID: 8944555 DOI: 10.1136/gut.39.4.501] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
29 Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 2003;55:247-252. [PMID: 12811429 DOI: 10.1007/s00251-003-0575-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
30 Hoensch HP, Weigmann B. Regulation of the intestinal immune system by flavonoids and its utility in chronic inflammatory bowel disease. World J Gastroenterol 2018; 24(8): 877-881 [PMID: 29491681 DOI: 10.3748/wjg.v24.i8.877] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Bendjelloul F, Rossmann P, Malý P, Mandys V, Jirkovská M, Prokesová L, Tucková L, Tlaskalová-Hogenová H. Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study. Histochem J 2000;32:703-9. [PMID: 11254085 DOI: 10.1023/a:1004191825644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
32 Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature. World J Gastroenterol 2008; 14(2): 165-173 [PMID: 18186549 DOI: 10.3748/wjg.14.165] [Cited by in CrossRef: 116] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
33 Freire P, Cardoso R, Figueiredo P, Donato MM, Ferreira M, Mendes S, Ferreira AM, Vasconcelos H, Portela F, Sofia C. NOD2 gene mutations in ulcerative colitis: useless or misunderstood? Int J Colorectal Dis. 2014;29:653-661. [PMID: 24651958 DOI: 10.1007/s00384-014-1850-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
34 Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. J Crohns Colitis. 2017;11:84-91. [PMID: 27466171 DOI: 10.1093/ecco-jcc/jjw132] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
35 Caviglia R, Ribolsi M, Rizzi M, Emerenziani S, Annunziata ML, Cicala M. Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up. World J Gastroenterol 2007; 13(39): 5238-5244 [PMID: 17876895 DOI: 10.3748/wjg.v13.i39.5238] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
36 Lian T, Wu Q, Hodge BA, Wilson KA, Yu G, Yang M. Drosophila Gut-A Nexus Between Dietary Restriction and Lifespan. Int J Mol Sci 2018;19:E3810. [PMID: 30501099 DOI: 10.3390/ijms19123810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Tsuruta T, Katsumata E, Mizote A, Jian HJ, Muhomah TA, Nishino N. Cyclic nigerosylnigerose ameliorates DSS-induced colitis with restoration of goblet cell number and increase in IgA reactivity against gut microbiota in mice. Biosci Microbiota Food Health 2020;39:188-96. [PMID: 32775139 DOI: 10.12938/bmfh.2020-012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Yang M, Bose S, Lim SK, Kim H. Preventive Effects of Pyungwi-san against Dextran Sulfate Sodium- and Clostridium difficile-Induced Inflammatory Bowel Disease in Mice. Int J Mol Sci. 2019;20:6346. [PMID: 31888274 DOI: 10.3390/ijms20246346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
39 Chang YC, Ching YH, Chiu CC, Liu JY, Hung SW, Huang WC, Huang YT, Chuang HL. TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice. PLoS One 2017;12:e0180025. [PMID: 28683149 DOI: 10.1371/journal.pone.0180025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
40 Kim I, Kong H, Lee Y, Hong S, Han J, Jung S, Jung Y, Kim YM. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine. Pharm Res 2009;26:415-21. [PMID: 18958401 DOI: 10.1007/s11095-008-9758-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
41 Hikasa Y, Nishikawa M, Hori K, Furukawa K, Yamada K, Tanida N, Shimoyama T. Leukotriene C4 D4 antagonist markedly reduced inflammation in a rat model of inflammatory bowel disease. Gastroenterol Jpn 1992;27:792. [PMID: 1468610 DOI: 10.1007/BF02806534] [Reference Citation Analysis]
42 Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 1996;98:1010-20. [PMID: 8770874 DOI: 10.1172/JCI118861] [Cited by in Crossref: 823] [Cited by in F6Publishing: 373] [Article Influence: 31.7] [Reference Citation Analysis]
43 Mittal NK, Kirschner BS. Chronic inflammatory bowel disease. Indian J Pediatr 1994;61:655-63. [PMID: 7721370 DOI: 10.1007/BF02751974] [Reference Citation Analysis]
44 Post S, Herfarth C, Böhm E, Timmermanns G, Schumacher H, Schürmann G, Golling M. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 1996;223:253-60. [PMID: 8604905 DOI: 10.1097/00000658-199603000-00005] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 3.4] [Reference Citation Analysis]
45 Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Dig Dis Sci 2021;66:2005-13. [PMID: 32617771 DOI: 10.1007/s10620-020-06439-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ma H, Tao W, Zhu S. T lymphocytes in the intestinal mucosa: defense and tolerance. Cell Mol Immunol 2019;16:216-24. [PMID: 30787416 DOI: 10.1038/s41423-019-0208-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
47 Van Klinken BJ, Van der Wal JW, Einerhand AW, Büller HA, Dekker J. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999;44:387-93. [PMID: 10026326 DOI: 10.1136/gut.44.3.387] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 3.9] [Reference Citation Analysis]
48 Feng BS, Chen X, Li P, Zheng PY, Chong J, Cho DB, He SH, Tang SG, Yang PC. Expression of integrin alphavbeta6 in the intestinal epithelial cells of patients with inflammatory bowel disease. N Am J Med Sci 2009;1:200-4. [PMID: 22666696 DOI: 10.4297/najms.2009.4200] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
49 Sawinski D, Uribarri J, Peace D, Yao T, Wauhop P, Trzcinka P, Ostrow K, Poggio ED, Heeger PS. 25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. Am J Transplant 2010;10:2287-95. [PMID: 20840475 DOI: 10.1111/j.1600-6143.2010.03264.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
50 Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008;29:369-375. [PMID: 18561994 DOI: 10.1016/j.mam.2008.04.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 6.1] [Reference Citation Analysis]
51 Xue FM, Zhang HP, Hao HJ, Shi ZY, Zhou C, Feng B, Yang PC. CD98 positive eosinophils contribute to T helper 1 pattern inflammation. PLoS One 2012;7:e51830. [PMID: 23272174 DOI: 10.1371/journal.pone.0051830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
52 Tavakoli P, Vollmer-Conna U, Hadzi-Pavlovic D, Grimm MC. A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Rev 2021;42:1603990. [PMID: 34692176 DOI: 10.3389/phrs.2021.1603990] [Reference Citation Analysis]
53 Fuse K, Katakura K, Sakamoto N, Ohira H. Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients. World J Gastroenterol 2010; 16(46): 5815-5821 [PMID: 21155002 DOI: 10.3748/wjg.v16.i46.5815] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
54 Onur H, Aral H, Arica V, Bercem GA, Kasapcopur O. Vitamin D levels in children with familial Mediterranean fever. Pediatr Rheumatol Online J 2016;14:28. [PMID: 27121284 DOI: 10.1186/s12969-016-0089-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
55 Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol. 2009;29:815-825. [PMID: 19653082 DOI: 10.1007/s10875-009-9320-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
56 Kutsuna R, Tomida J, Morita Y, Kawamura Y. Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis. PLoS One 2018;13:e0197668. [PMID: 29782507 DOI: 10.1371/journal.pone.0197668] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Crotty B, Jewell DP. Drug therapy of ulcerative colitis. Br J Clin Pharmacol 1992;34:189-98. [PMID: 1389944 DOI: 10.1111/j.1365-2125.1992.tb04124.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 1.6] [Reference Citation Analysis]
58 Tytgat KM, Opdam FJ, Einerhand AW, Büller HA, Dekker J. MUC2 is the prominent colonic mucin expressed in ulcerative colitis. Gut. 1996;38:554-563. [PMID: 8707087 DOI: 10.1136/gut.38.4.554] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis]
59 Hayashi R, Tahara T, Yamaaki T, Saito T, Matsunaga K, Hayashi N, Fukumura A, Ozaki K, Nakamura M, Shiroeda H, Tsutsumi M, Shibata T, Arisawa T. -449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis. World J Gastroenterol 2012; 18(47): 6981-6986 [PMID: 23322997 DOI: 10.3748/wjg.v18.i47.6981] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 1997;41:793-800. [PMID: 9462212 DOI: 10.1136/gut.41.6.793] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lee SA, Wang Y, Liu F, Riordan SM, Liu L, Zhang L. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway. Infect Immun 2020;89:e00618-20. [PMID: 33046511 DOI: 10.1128/IAI.00618-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998;62:1157-70. [PMID: 9841668 DOI: 10.1128/MMBR.62.4.1157-1170.1998] [Cited by in Crossref: 419] [Cited by in F6Publishing: 134] [Article Influence: 18.2] [Reference Citation Analysis]
63 Tzanakis NE, Tsiligianni IG, Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010; 16(3): 299-305 [PMID: 20082474 DOI: 10.3748/wjg.v16.i3.299] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
64 Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 2001;48:461-7. [PMID: 11247888 DOI: 10.1136/gut.48.4.461] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
65 Ge J, Zhang X, Liu J, Fu Z, Shi X, Li Q, Liu J, Zhu Q. Elevated expression of interleukin-21 and its correlation to T-cell subpopulation in patients with ulcerative colitis. Cent Eur J Immunol 2015;40:331-6. [PMID: 26648777 DOI: 10.5114/ceji.2015.54595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
66 Lee Y, Jeong S, Kim W, Kim H, Yoon JH, Jeong SH, Jung Y. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis. Dig Dis Sci 2013;58:1226-34. [PMID: 23192646 DOI: 10.1007/s10620-012-2495-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
67 Tsiveriotis K, Tsirogianni A, Pipi E, Soufleros K, Papasteriades C. Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis 2011;2011:626495. [PMID: 21687647 DOI: 10.4061/2011/626495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
68 Jayawardena D, Anbazhagan AN, Guzman G, Dudeja PK, Onyuksel H. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease. Mol Pharm. 2017;14:3698-3708. [PMID: 28991483 DOI: 10.1021/acs.molpharmaceut.7b00452] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
69 Watanabe M, Ueno Y, Yajima T, Okamoto S, Hayashi T, Yamazaki M, Iwao Y, Ishii H, Habu S, Uehira M, Nishimoto H, Ishikawa H, Hata J, Hibi T. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998;187:389-402. [PMID: 9449719 DOI: 10.1084/jem.187.3.389] [Cited by in Crossref: 156] [Cited by in F6Publishing: 135] [Article Influence: 6.5] [Reference Citation Analysis]
70 Li N, Ghia JE, Wang H, McClemens J, Cote F, Suehiro Y, Mallet J, Khan WI. Serotonin activates dendritic cell function in the context of gut inflammation. Am J Pathol 2011;178:662-71. [PMID: 21281798 DOI: 10.1016/j.ajpath.2010.10.028] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
71 Karban A, Atia O, Leitersdorf E, Shahbari A, Sbeit W, Ackerman Z, Mualem R, Levine A, Nesher S, Safadi R, Eliakim R. The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohort. Dig Dis Sci 2005;50:1692-7. [PMID: 16133971 DOI: 10.1007/s10620-005-2917-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
72 Dutra RC, Cola M, Leite DF, Bento AF, Claudino RF, Nascimento AF, Leal PC, Calixto JB. Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells. Br J Pharmacol. 2011;163:358-374. [PMID: 21244371 DOI: 10.1111/j.1476-5381.2011.01226.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
73 Ye Z, Liu Z, Henderson A, Lee K, Hostetter J, Wannemuehler M, Hendrich S. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp Biol Med (Maywood). 2009;234:605-616. [PMID: 19307459 DOI: 10.3181/0901-rm-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
74 Lee SK, Kim YW, Chi SG, Joo YS, Kim HJ. The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci. 2009;54:255-263. [PMID: 18612822 DOI: 10.1007/s10620-008-0357-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
75 Urabe S, Isomoto H, Ishida T, Maeda K, Inamine T, Kondo S, Higuchi N, Sato K, Uehara R, Yajima H, Machida H, Chen CC, Fukuda Y, Takeshima F, Nakao K, Tsukamoto K. Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. Biomed Res Int 2015;2015:416838. [PMID: 26558270 DOI: 10.1155/2015/416838] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
76 Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, Targan SR, Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68:1542-1548. [PMID: 10678972 DOI: 10.1128/iai.68.3.1542-1548.2000] [Cited by in Crossref: 143] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
77 Wild GE, Drozdowski L, Tartaglia C, Clandinin MT, Thomson AB. Nutritional modulation of the inflammatory response in inflammatory bowel disease- From the molecular to the integrative to the clinical. World J Gastroenterol 2007; 13(1): 1-7 [PMID: 17206749 DOI: 10.3748/wjg.v13.i1.1] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
78 Matsumoto S, Hara T, Nagaoka M, Mike A, Mitsuyama K, Sako T, Yamamoto M, Kado S, Takada T. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer. Immunology. 2009;128:e170-e180. [PMID: 19740306 DOI: 10.1111/j.1365-2567.2008.02942.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
79 Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38:365-375. [PMID: 8675088 DOI: 10.1136/gut.38.3.365] [Cited by in Crossref: 307] [Cited by in F6Publishing: 281] [Article Influence: 11.8] [Reference Citation Analysis]
80 Park J, Lee IS, Kim KH, Kim Y, An EJ, Jang HJ. GI inflammation Increases Sodium-Glucose Cotransporter Sglt1. Int J Mol Sci 2019;20:E2537. [PMID: 31126070 DOI: 10.3390/ijms20102537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
81 Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut. 1997;41:209-214. [PMID: 9301500 DOI: 10.1136/gut.41.2.209] [Cited by in Crossref: 226] [Cited by in F6Publishing: 201] [Article Influence: 9.0] [Reference Citation Analysis]
82 Shen C, Landers CJ, Derkowski C, Elson CO, Targan SR. Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease. Inflamm Bowel Dis 2008;14:1641-51. [PMID: 18825772 DOI: 10.1002/ibd.20645] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
83 Panhuysen CI, Karban A, Knodle Manning A, Bayless TM, Duerr RH, Bailey-Wilson JE, Epstein EH Jr, Brant SR. Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree. Hum Genet 2006;120:31-41. [PMID: 16733713 DOI: 10.1007/s00439-006-0163-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
84 Cheah KY, Bastian SE, Acott TM, Abimosleh SM, Lymn KA, Howarth GS. Grape seed extract reduces the severity of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats. Dig Dis Sci. 2013;58:970-977. [PMID: 23143736 DOI: 10.1007/s10620-012-2464-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
85 Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H. Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig Dis Sci 1997;42:1593-7. [PMID: 9286222 DOI: 10.1023/a:1018832608899] [Cited by in Crossref: 29] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
86 Lashgari NA, Roudsari NM, Zandi N, Pazoki B, Rezaei A, Hashemi M, Momtaz S, Rahimi R, Shayan M, Dehpour AR, Abdolghaffari AH. Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Mol Biol Rep 2021;48:855-74. [PMID: 33394234 DOI: 10.1007/s11033-020-06095-x] [Reference Citation Analysis]